0001140361-25-034438
SEC filingRevenue declined slightly, gross margins contracted due to unfavorable product mix, while FPD segment growth partially offset IC weakness.
In Q3 FY25, total revenue was $210.4 million, flat compared to both Q2 FY25 and Q3 FY24. Gross profit decreased to $70.9 million, resulting in a gross margin of 33.7%, down 320 basis points sequentially and 190 basis points year-over-year. The margin contraction was attributed to an unfavorable product mix, with material costs increasing 8.2% sequentially (207 bps) and 11.4% year-over-year (278 bps), partially offset by declines in other costs. Operating income margin also fell to 22.9% from 24.7% in the prior year quarter. Net income attributable to Photronics shareholders was $22.9 million ($0.39 per diluted share), compared to $34.4 million ($0.55 per diluted share) in Q3 FY24. Net income was negatively impacted by other expense of $9.4 million, primarily from foreign currency losses on the New Taiwan dollar and South Korean won.
IC revenue declined 5.2% both quarter-over-quarter and year-over-year, to $147.8 million. Mainstream IC revenue in Asia faced continued headwinds from geopolitical trade restrictions and tariff negotiations, partially offset by strong high-end demand in the United States. FPD revenue increased 13.5% sequentially and 13.6% year-over-year to $62.6 million, driven by high-end growth of 22.6% QoQ and 10.5% YoY, particularly in South Korea. Mainstream FPD also grew 35.5% YoY. Revenue by geography showed strength in South Korea (up 13.8% YoY) and the United States (up 22.9% QoQ, but down 2.8% YoY), while China and Europe declined.
Management did not provide specific numerical guidance in the MD&A, but referenced the Q3 FY25 earnings press release and conference call for outlook. Capital expenditures for fiscal 2025 are estimated at approximately $200 million, mainly in Asia and the U.S., targeted at high-end and mainstream capacity to support customer demand. As of August 3, 2025, the company had outstanding capital commitments of $147.2 million. Liquidity remains strong with $479.5 million in cash and cash equivalents, including $416.1 million held by foreign subsidiaries. The company also has a share repurchase authorization with $27.6 million remaining. Management believes existing liquidity and cash generation are sufficient to meet requirements through the next twelve months and beyond.
Net income for the period was $111.6M (prior: $143.6M), while operating cash flow was $160.0M (prior: $193.1M). Operating cash flow exceeded net income due to non-cash charges (depreciation & amortization of $59.2M and share-based compensation of $10.0M). However, working capital consumed $20.9M (excluding depreciation and share compensation), primarily from an increase in inventories ($6.1M), other current assets ($8.0M), and a decrease in payables ($19.2M), partially offset by a decrease in accounts receivable ($12.4M).
Capital expenditures rose to $120.6M (from $87.7M), reflecting continued investment in manufacturing capacity. The company funded these investments through operating cash flow and short-term investment liquidations. Despite the capex increase, the company returned $97.4M to shareholders via stock repurchases, with no dividends paid. The combination of capex and buybacks exceeded operating cash flow, leading to a net cash outflow of $118.8M for the period.
No significant anomalies noted. The small government incentives ($1.5M) and effects of exchange rate changes ($10.1M positive) had a minor impact. The repayment of debt ($18.0M) was higher than the prior year ($4.5M).